The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome
Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
---|---|
Data(s) |
17/04/2012
17/04/2012
2010
|
Resumo |
Background: Obstructive Sleep Apnea (OSA) is tightly linked to some components of Metabolic Syndrome (MetS). However, most of the evidence evaluated individual components of the MetS or patients with a diagnosis of OSA that were referred for sleep studies due to sleep complaints. Therefore, it is not clear whether OSA exacerbates the metabolic abnormalities in a representative sample of patients with MetS. Methodology/Principal Findings: We studied 152 consecutive patients (age 48 +/- 9 years, body mass index 32.3 +/- 3.4 Kg/m(2)) newly diagnosed with MetS (Adult Treatment Panel III). All participants underwent standard polysomnography irrespective of sleep complaints, and laboratory measurements (glucose, lipid profile, uric acid and C-reactive protein). The prevalence of OSA (apnea-hypopnea index >= 15 events per hour of sleep) was 60.5%. Patients with OSA exhibited significantly higher levels of blood pressure, glucose, triglycerides, cholesterol, LDL, cholesterol/HDL ratio, triglycerides/HDL ratio, uric acid and C-reactive protein than patients without OSA. OSA was independently associated with 2 MetS criteria: triglycerides: OR: 3.26 (1.47-7.21) and glucose: OR: 2.31 (1.12-4.80). OSA was also independently associated with increased cholesterol/HDL ratio: OR: 2.38 (1.08-5.24), uric acid: OR: 4.19 (1.70-10.35) and C-reactive protein: OR: 6.10 (2.64-14.11). Indices of sleep apnea severity, apnea-hypopnea index and minimum oxygen saturation, were independently associated with increased levels of triglycerides, glucose as well as cholesterol/HDL ratio, uric acid and C-reactive protein. Excessive daytime sleepiness had no effect on the metabolic and inflammatory parameters. Conclusions/Significance: Unrecognized OSA is common in consecutive patients with MetS. OSA may contribute to metabolic dysregulation and systemic inflammation in patients with MetS, regardless of symptoms of daytime sleepiness. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)[200032/2009-7] Fundacao Zerbini, Brazil National Sleep Foundation/American Lung Association Pickwick[SF-78568 N] National Institutes of Health (NIH)[HL07534] National Institutes of Health (NIH)[R01 HL80105] National Institutes of Health (NIH)[5P50HL084945] American Heart Association[0765293U] (BSF) United States Israel Binational Science Foundation[2005265] |
Identificador |
PLOS ONE, v.5, n.8, 2010 1932-6203 http://producao.usp.br/handle/BDPI/14596 10.1371/journal.pone.0012065 |
Idioma(s) |
eng |
Publicador |
PUBLIC LIBRARY SCIENCE |
Relação |
Plos One |
Direitos |
openAccess Copyright PUBLIC LIBRARY SCIENCE |
Palavras-Chave | #C-REACTIVE PROTEIN #INCIDENT CARDIOVASCULAR EVENTS #URIC-ACID LEVELS #INTERMITTENT HYPOXIA #INSULIN-RESISTANCE #DAYTIME SLEEPINESS #VISCERAL OBESITY #RISK #POPULATION #MORTALITY #Biology #Multidisciplinary Sciences |
Tipo |
article original article publishedVersion |